CAS 167221-71-8
:Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime thyl-3,5-pyridinedicarboxylate
- 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
- 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester
- 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-Pyridinedicarboxylic acid methyl (1-oxobutoxy)methyl ester
- Clevelox
- Clevidipine
- Clevidipine butyrate
- Cleviprex
- H 324/38
- rac-Clevidipine
- Cleviprex (Clevidipine)
- 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-diMethyl-3,5-pyridinedicarboxylic Acid 3-Methyl 5-[(1-Oxobutoxy)Methyl] Ester
- 3-((Butyryloxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
- CS-136
- evidipine
- 5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
- 3,5-Pyridinedicarboxylicacid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl5-[(1-oxobutoxy)methyl] ester
- 3-((Butyryloxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-di
- Clevidipine Butyrate/Cleviprex
- Cloweidipine butyrate
- Butyric acid Clevidipine
- Clevidipine butyrate USP/EP/BP
- 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic Aicd 3-[(Butyryloxy)methyl] 5-Methyl Ester
- Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime thyl-3,5-pyridinedicarboxylate
- Clevidipine, Cleviprex
- See more synonyms
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
CAS:Formula:C21H23Cl2NO6Purity:97%Color and Shape:SolidMolecular weight:456.3164Clevidipine
CAS:Clevidipine (Clevidipine butyrate) is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for bloodFormula:C21H23Cl2NO6Purity:99.40%Color and Shape:PowderMolecular weight:456.32Clevidipine butyrate
CAS:Formula:C21H23Cl2NO6Purity:≥ 99.0%Color and Shape:White to beige powderMolecular weight:456.32Clevidipine-d7
CAS:Formula:C21H16D7Cl2NO6Color and Shape:White To Off-White SolidMolecular weight:463.36Clevidipine
CAS:Formula:C21H23Cl2NO6Purity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:456.32Clevidipine
CAS:Controlled ProductApplications Calcium channel blocker, used as an oral antihypertensive.
References Odenstedt, J., et al.: J. Cardiovas., Pharmacol., 44, 407 (2004), Tang, H., et al.: J. Pharm. Sci., 95, 1783 (2006), Obach, R., et al.: Drug Metab. Disposition, 36, 1385 (2008), Varon, J., et al.: Drugs, 68, 283 (2008),Formula:C21H23Cl2NO6Color and Shape:Off White SolidMolecular weight:456.323,5-PYRIDINEDICARBOXYLIC ACID, 4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3-METHYL 5-[(1-OXOBUTOXY)METHYL] ESTER
CAS:Purity:97%Molecular weight:456.3200073Clevidipine
CAS:Clevidipine is a drug that is used to treat high blood pressure, angina, and chest pain. It belongs to the group of calcium channel blockers and has a molecular weight of 438.5 daltons. Clevidipine inhibits the enzyme activity of phosphodiesterase type III (PDE-III) and phosphodiesterase type IV (PDE-IV). These enzymes break down cyclic guanosine monophosphate (cGMP) which is an important second messenger in the formation of cAMP. Clevidipine also has cardiac effects including vasodilating effects on coronary arteries, slowing heart rate, decreasing myocardial contractility, and reducing myocardial oxygen demand. Clevidipine binds to human serum albumin and can be injected intravenously or orally. This drug may interact with other drugs such as antimicrobial agents which may alter its metabolism or effectiveness.>>END>>
Formula:C21H23Cl2NO6Purity:Min. 95%Molecular weight:456.32 g/mol








